<DOC>
	<DOCNO>NCT02411500</DOCNO>
	<brief_summary>The primary objective study evaluate pharmacokinetics various TRV734 formulation healthy male subject .</brief_summary>
	<brief_title>A Pharmacokinetic , Safety Tolerability Study Healthy Adult Males</brief_title>
	<detailed_description />
	<criteria>Healthy determine responsible physician train qualified designee Males : 18 55 year inclusive screen Capable give write informed consent Clinically significant condition history faint syncope Medical psychiatric illness could interfere completion treatment follow Major surgery within 4weeks screen Known difficulty obtain intravenous access History sensitivity study medication , intolerance opioids , history medication allergy contraindicates participation Use prescription nonprescription medication History excessive alcohol use History drug abuse within 6 month screen Use illegal drug within 30 day screen throughout participation study History smoking use nicotine containing product within 3 month screen throughout participation study Donation blood plasma 4 week prior dose Participation clinical trial receive medication within 30 day Weight &lt; 50 kg BMI outside range 1832 kg/m2 Positive HIV antibody , hepatitis B virus surface antigen , hepatitis C virus Unwillingness abstain sexual intercourse pregnant lactate woman , engage sexual intercourse female partner childbearing potential , use condom spermicide , addition female partner use another form contraception , abstain sperm donation</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Male</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>